Zydus Lifesciences acquires rights to market MonoFerric injections in India and Nepal
MonoFerric, iron isomaltoside 1000 solution for injection/infusion, is a rapid, single dose IV iron developed to reduce the number of infusions
MonoFerric, iron isomaltoside 1000 solution for injection/infusion, is a rapid, single dose IV iron developed to reduce the number of infusions
The Allurion Program is suited for people who are unable to achieve their weight-loss goals by dieting alone or for those who do not want to, or cannot, undergo invasive surgery or endoscopy
Two main objectives are: Accelerate novel technologies and products for global markets; and Connect academia and industry, creating synergy for faster advancement of the Bioprotection sector
India is an example in front of the world to contribute towards strengthening Points of Entry during a public health emergency
This partnership aims to embed latest technological advancements in diagnosing and managing lung disorders and associated non-communicable diseases like asthma, pulmonary fibrosis and COPD.
India is at the forefront of research in cardiology worldwide but making indigenous products is what we are lacking & it needs to be improved
The Centre aims at promoting innovation among the scientific community to improve healthcare solutions around the globe
It is high time that India assumed a leadership role in healthcare.
Granules now have a total of 51 ANDA approvals from US FDA (49 Final approvals and 2 tentative approvals).
Subscribe To Our Newsletter & Stay Updated